Neuron specific enolase and C-reactive protein levels in stroke and its subtypes: Correlation with degree of disability

Neurochemical Research

Volumn 39, Issue 8, 2014, Pages 1426-1432

  Pandey, Aparna ^a   Shrivastava, Amit Kumar ^b   Saxena, Kiran ^c  

^a Department of Biochemistry Narshinbhai Patel Dental College and Hospital   (India)

^b Sudha Rustagi College of Dental Sciences and Research   (India)

^c Chirayu Medical College and Hospital   (India)

Author keywords

C reactive protein; National Institutes of Health Stroke Scale; Neuron specific enolase; Stroke

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENOLASE;

AGED; BLOOD; CLASSIFICATION; DISABLED PERSON; FEMALE; HUMAN; INDIA; MALE; METABOLISM; MIDDLE AGED; STROKE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISABLED PERSONS; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; STROKE;

EID: 84905703202     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1328-9     Document Type: Article

References (34)

1. Kim MH, Kang SY, Kim MC, Lee WI (2010) Plasma biomarkers in the diagnosis of acute ischemic stroke. Ann Clin Lab Sci 40:336-341
2. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al (2011) Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:227-276
3. Steinwachs DM, Collins-Nakai RL, Cohn LH, Garson A Jr, Wolk MJ (2000) The future of cardiology: utilization and costs of care. J Am Coll Cardiol 35:1092-1099 (Pubitemid 30189945)
4. Mathers CD, Lopez AD, Murray CJL (2006) The burden of disease and mortality by condition: data, methods, and results for 2001. In: Lopez AD, Mathers CD, Ezzati M et al (eds) Global burden of disease and risk factors. World Bank, Washington
5. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF et al (1991) Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 21:497-500
6. Hardemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y et al (1989) S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 71:727-731 (Pubitemid 19275772)
7. Di Napoli M, Elkind MS, Godoy DA, Singh P, Papa F, Popa-Wagner A (2011) Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther 9:1565-1584
8. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843 (Pubitemid 30165206)
9. Ridker PM (2000) Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation 105:2583-2585
10. Kwan J, Hand P (2006) Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM 99:625-633 (Pubitemid 44540538)
11. Feigin V, Lawes C, Bennet D, Barker Cello S, Parag V (2009) Worldwide stroke incidence and early case fatality in 56 population based studies: a systematic review. Lancet Neurol 8:355-369
12. Pandian J, Jaison A, Deepak SS, Kalra G, Shamsher S, Lincoln DJ et al (2005) Public awareness of warning symptoms, risk factors and treatment of stroke in Northwest India. Stroke 36:644-648 (Pubitemid 40344171)
13. Sethi P (2002) Stroke-incidence in India and management of ischaemic stroke. Neurosciences 4:139-141
14. Das S, Banerjee T (2008) Stroke Indian scenario. Circulation 118:2719-2724
15. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC et al (1999) Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 30:1528-1533 (Pubitemid 29379597)
16. Kaca-Oryńska M, Tomasiuk R, Friedman A (2010) Neuronspecific enolase and S 100B protein as predictors of outcome in ischaemic stroke. Neurol Neurochir Pol 44:459-463
17. Selakovic V, Raicevic R, Radenovic L (2005) The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 12:542-547 (Pubitemid 41044195)
18. Pandey A, Saxena K, Verma M, Bharosay A (2011) Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients. J Neurosci Rural Pract 2:50-54
19. Brea D, Sobrino T, Blanco M, Cristobo I, Rodríguez-González R, Rodríguez-Yañez M et al (2009) Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke. Clin Chem Lab Med 47:1513-1518
20. Dwi Lily L, Endang Retnowati K (2007) Role of serum neuron specific enolase (NSE) to differentiate ischemic stroke from hemorrhagic stroke and its correlation with brain damage volume. Folia Med Indones 43:230-234
21. Klaus KA, Olsen TS, Dehlendorff C, Kammersgaard LP (2009) Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 40:2068-2072
22. Bharosay A, Bharosay VV, Varma M, Saxena K, Sodani A, Saxena R (2012) Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Indian J Clin Biochem 27:186-190
23. Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M et al (1997) Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 148:101-105 (Pubitemid 27149530)
24. Missler U, Wiesmann M, Friedrich C, Kaps M (1997) S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956-1960 (Pubitemid 27459003)
25. Bharosay A, Saxena K, Varma M, Bharosay VV, Pandey A (2011) Correlation between proinflammatory serum markers: high sensitivity C-reactive protein, interleukin-6 with disability score in acute ischemic stroke. Indian J Clin Biochem 26:279-282
26. Di Napoli M, Papa F, Bocola V (2001) Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32:133-138 (Pubitemid 32063837)
27. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C et al (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 36:1316-1329 (Pubitemid 40798763)
28. Eikelboom JW, Hankey GJ, Baker RI, McQuillan A, Thom J, Staton J et al (2003) C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 12:74-81 (Pubitemid 36506246)
29. Mishra PT, Chandra R, Saxena SK, Verma S, Jain R, Bhuyan A (2010) High sensitivity C-reactive protein (hsCRP) level in cerebrovascular accident (stroke). JIACM 11:204-207
30. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J et al (2005) C reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population. Stroke 37:27-32
31. Elkind MS, Tai W, Coates K, Paik MC, Sacco RL (2006) High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and outcome after ischemic stroke. Arch Intern Med 166:2073-2080 (Pubitemid 44631394)
32. Kumar SS, Grant PJ, Catto AJ, Bamford JM, Carter A (2009) Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke 40:977-979
33. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P (2006) Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 37:2018-2023 (Pubitemid 44309897)
34. Audebert HJ, Rott MM, Eck T, Haberl RL (2004) Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke 35:2128-2133 (Pubitemid 39129573)